3 research outputs found
Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients
This study aimed to evaluate the effects of antiretroviral therapy on plasmacytoid (pDC) and myeloid
(mDC) dendritic cells as well as regulatory T (Treg) and myeloid-derived suppressor (MDSC) cells in HIVinfected
patients. Forty-five HIV-infected patients (20 of them with detectable HIV load −10 recently
infected and 10 chronically infected patients-, at baseline and after antiretroviral therapy, and 25 with
undetectable viral loads) and 20 healthy controls were studied. The influence of HIV load, bacterial
translocation (measured by 16S rDNA and lipopolysaccharide-binding protein) and immune activation
markers (interleukin –IL- 6, soluble CD14, activated T cells) was analyzed. The absolute numbers and
percentages of pDC and mDC were significantly increased in patients. Patients with detectable viral
load exhibited increased intracellular expression of IL-12 by mDCs and interferon -IFN- α by pDCs.
Activated population markers were elevated, and the proportion of Tregs was significantly higher in
HIV-infected patients. The MDSC percentage was similar in patients and controls, but the intracellular
expression of IL-10 was significantly higher in patients. The achievement of undetectable HIV load
after therapy did not modify bacterial translocation parameters, but induce an increase in pDCs, mDCs
and MDSCs only in recently infected patients. Our data support the importance of early antiretroviral
therapy to preserve dendritic and regulatory cell function in HIV-infected individuals
CD4+ T Cell Depletion, Immune Activation and Increased Production of Regulatory T Cells in the Thymus of HIV-Infected Individuals
Mechanisms by which HIV affects the thymus are multiple and only partially known, and the role of thymic dysfunction in HIV/AIDS immunopathogenesis remains poorly understood. To evaluate the effects of HIV infection on intra-thymic precursors of T cells in HIV-infected adults, we conducted a detailed immunophenotypic study of thymic tissue isolated from 7 HIV-infected and 10 HIV-negative adults who were to undergo heart surgery. We found that thymuses of HIV-infected individuals were characterized by a relative depletion of CD4+ single positive T cells and a corresponding enrichment of CD8+ single positive T cells. In addition, thymocytes derived from HIV-infected subjects showed increased levels of activated and proliferating cells. Our analysis also revealed a decreased expression of interleukin-7 receptor in early thymocytes from HIV-infected individuals, along with an increase in this same expression in mature double- and single-positive cells. Frequency of regulatory T cells (CD25+FoxP3+) was significantly increased in HIV-infected thymuses, particularly in priorly-committed CD4 single positive cells. Our data suggest that HIV infection is associated with a complex set of changes in the immunophenotype of thymocytes, including a reduction of intrathymic CD4+ T cell precursors, increased expression of activation markers, changes in the expression pattern of IL-7R and enrichment of T regulatory cells generation
Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance
There are many ways in which neuronal damage can be produced in the brain, including the overactivation of depolarizing receptors, exposure to high levels of pro-inflammatory proteins such as cytokines, or miscellaneous toxins, but the kynurenine pathway has emerged as a novel but potentially major factor in regulating neuronal viability or death. It is the major route for the metabolism of the essential amino acid tryptophan, which is oxidized by indoleamine-2,3-dioxygenase (IDO) to a series of compounds which can activate, block, or modulate conventional neurotransmitter receptors. Quinolinic acid is an agonist at N-methyl-d-aspartate receptors, kynurenic acid is an antagonist at these and other glutamate receptors, and other kynurenine metabolites are highly redox-active. Superimposed on the discovery of this neuromodulatory pathway have been observations that activity in the pathway is linked to neurological and psychiatric disorders, correlating with disease state (as in Huntington’s disease) or cognitive function (as following bypass surgery). Together, the data accumulated to date make a strong case for this hitherto obscure pathway being a major factor in determining cell damage, death, or recovery in health and disease